Author

C. Montalto

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Timing of revascularisation in patients undergoing high-risk percutaneous coronary intervention and Transcatheter aortic valve implantation: insights from the ASCoP registry.

BACKGROUND Evidence on the management of complex and high-risk coronary artery disease (CAD) in patients undergoing transcatheter aortic valve implantation (TAVI) is still limited. In particular, the optimal timing of percutaneous coronary intervention (PCI) relative to TAVI remains uncertain. METHODS The ASCop is an...

A. Munafò, Giuseppe Esposito, A. Khokhar et al. · International Journal of Car... · 0 citations

Review Open access Sep 2026

Moderate aortic stenosis: diagnostic pitfalls and the role of multimodality imaging in risk stratification and clinical management

Moderate aortic stenosis (AS) has traditionally been considered a transitional and relatively benign stage of valvular disease. Yet, contemporary evidence shows that it is associated with substantial morbidity and mortality even before progression to severe AS. This paper synthesizes current evidence on the limitations...

G. Santangelo, A. Maloberti, C. Tognola et al. · Cardiovascular Ultrasound · 0 citations

Aug 2026

De-escalation of antiplatelet therapy to evaluate platelet reactivity and clinical outcomes after coronary stenting in patients at high bleeding risk and recent acute coronary syndrome: Rationale and design of the DESC-HBR trial.

DesC-HBR is the first randomized trial directly comparing multiple P2Y12 inhibitor de-escalation strategies in HBR patients post-ACS and will provide information to guide individualized antiplatelet strategies balancing ischemic protection and bleeding mitigation in HBR patients.

Francesco Costa, G. Vizzari, S. Zecchino et al. · Cardiovascular Revasculariza... · 0 citations